How do clinicians respond to the sizable volume of patients with end-stage renal disease but who don't want conventional care?
This is the Center for Dialysis Innovation’s third award in the ongoing international KidneyX competition.
At-home dialysis is a U.S. priority to stem the growing burden of care that involves people with chronic kidney disease.
Nephrology researcher "Beno" Freedman explores why, in about 25% of hospitalized patients, the virus damages the kidneys' filtering function.
In survey, nearly 85% desire resuscitation in the event of cardiac arrest, even though likely outcomes are poor, relative to the general population.
The Center for Dialysis Innovation earns acclaim for a porous synthetic graft intended to make the blood-cleansing process safer and more reliable.
Study indicates many are overly optimistic about, or not aware of, their likely prognosis – which may contribute to more aggressive end-of-life care.
UW center submitted 2 of 16 concepts chosen as finalists; focus is relief for kidney-failure patients.
Patients have treatment options that clinicians should employ, says the study’s lead author.
By clustering patients based on blood levels of select biomarkers, researchers learned who is likelier to benefit from a specific therapy.